Treace Medical Concepts, Inc. (TMCI) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

Core Viewpoint - Investors in Treace Medical Concepts, Inc. have the opportunity to lead a securities fraud class action lawsuit due to undisclosed competitive impacts on the company's primary product and misleading statements from the defendants [1][2]. Summary by Relevant Sections Lawsuit Details - The lawsuit alleges that from May 8, 2023, to May 7, 2024, Treace Medical's defendants failed to disclose that competition affected the demand and utilization of the Lapiplasty 3D Bunion Correction System [2] - As a result of competitive pressures, Treace Medical's revenue declined, prompting the company to accelerate plans for an alternative product to osteotomy [2] - The defendants' positive statements regarding the company's business and prospects were materially misleading and lacked a reasonable basis during the relevant period [2] Participation Information - Investors who suffered losses in Treace Medical are encouraged to participate in the ongoing securities fraud lawsuit before the lead plaintiff deadline of June 10, 2025 [2] - Interested parties can contact the Law Offices of Frank R. Cruz for more information on participation [3][4]